Ohio State University Comprehensive Cancer Center
Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing
- First Posted Date
- 2014-03-18
- Last Posted Date
- 2024-10-30
- Target Recruit Count
- 1000
- Registration Number
- NCT02090530
- Locations
- 🇺🇸
Ohio State University Wexner Medical Center, Columbus, Ohio, United States
Lenalidomide and Pidilizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma
- Conditions
- Interventions
- First Posted Date
- 2014-03-04
- Last Posted Date
- 2023-01-27
- Target Recruit Count
- 20
- Registration Number
- NCT02077959
- Locations
- 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, United States
Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by Surgery
- First Posted Date
- 2014-02-26
- Last Posted Date
- 2022-09-30
- Target Recruit Count
- 290
- Registration Number
- NCT02072356
- Locations
- 🇺🇸
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, United States
Stress Management for Cancer Patients: How Well Does it Work? (C2H-D)
- Conditions
- Interventions
- First Posted Date
- 2014-02-25
- Last Posted Date
- 2021-09-17
- Target Recruit Count
- 158
- Registration Number
- NCT02070250
- Locations
- 🇺🇸
Baylor Regional Medical Center at Plano, Texas, Plano, Texas, United States
🇺🇸IU Health Ball Memorial Hospital, Muncie, Indiana, United States
🇺🇸Genesis Health Center, Davenport, Iowa, United States
Biomarker Identification for Bladder Cancer Patients
- Conditions
- Interventions
- First Posted Date
- 2014-02-04
- Last Posted Date
- 2021-03-15
- Target Recruit Count
- 179
- Registration Number
- NCT02053662
- Locations
- 🇺🇸
The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Intensive Diet and Exercise or Standard of Care in Improving Physical Function and Quality of Life in Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy
- Conditions
- Interventions
- First Posted Date
- 2014-01-31
- Last Posted Date
- 2023-09-15
- Target Recruit Count
- 32
- Registration Number
- NCT02050906
- Locations
- 🇺🇸
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, United States
Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
- Conditions
- Recurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland CancerRecurrent Squamous Cell Carcinoma of the HypopharynxStage IVA Salivary Gland CancerMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Squamous Cell Carcinoma of the Lip and Oral CavityStage IV Squamous Cell Carcinoma of the HypopharynxStage IVA Oral Cavity Squamous Cell CarcinomaStage IVA Squamous Cell Carcinoma of the OropharynxStage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity
- Interventions
- First Posted Date
- 2014-01-14
- Last Posted Date
- 2018-05-24
- Target Recruit Count
- 3
- Registration Number
- NCT02035527
- Locations
- 🇺🇸
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, United States
Comprehensive Frailty Assessment
- Conditions
- First Posted Date
- 2014-01-13
- Last Posted Date
- 2018-02-28
- Target Recruit Count
- 111
- Registration Number
- NCT02033928
- Locations
- 🇺🇸
The Ohio State University Hospital East, Columbus, Ohio, United States
Pulmonary Rehabilitation in Improving Lung Function in Patients With Locally Advanced Non-Small Cell Lung Cancer Undergoing Chemoradiation
- Conditions
- Interventions
Phase II MOR00208 in Combination With Lenalidomide for Patients With Relapsed or Refractory CLL, SLL or PLL or Older Patients With Untreated CLL, SLL or PLL
- Conditions
- Prolymphocytic LeukemiaContiguous Stage II Small Lymphocytic LymphomaRefractory Chronic Lymphocytic LeukemiaStage II Chronic Lymphocytic LeukemiaNoncontiguous Stage II Small Lymphocytic LymphomaStage I Small Lymphocytic LymphomaStage III Small Lymphocytic LymphomaStage I Chronic Lymphocytic LeukemiaStage III Chronic Lymphocytic LeukemiaStage IV Small Lymphocytic Lymphoma
- Interventions
- First Posted Date
- 2013-12-09
- Last Posted Date
- 2024-05-17
- Target Recruit Count
- 41
- Registration Number
- NCT02005289
- Locations
- 🇺🇸
The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States